|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02561 VISEN PHARMA-B
Nominal 
() Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 277 | -68.379% | 876 | 2,352 |
| Land & other Lease Assets | 10,879 | -12.117% | 12,379 | 14,812 |
| Intangible Assets | 54 | -90.476% | 567 | 1,415 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 60,040 | 7.496% | 55,853 | 11,103 |
| 71,250 | 2.260% | 69,675 | 29,682 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 203,587 | -41.461% | 347,782 | 626,458 | |
| Other Current Assets | 18,986 | -27.917% | 26,339 | 85,132 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 222,573 | -40.508% | 374,121 | 711,590 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 835 | 24.813% | 669 | 3,740 | ||
| S-T Debt & Leases | 1,997 | -21.748% | 2,552 | 4,668 | ||
| Other Current Liabilities | 49,356 | 1.549% | 48,603 | 78,931 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 52,188 | 0.702% | 51,824 | 87,339 | |||
| Net Current Assets | 170,385 | -47.134% | 322,297 | 624,251 | ||
| Total Assets Less Current Liabilities | 241,635 | -38.354% | 391,972 | 653,933 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 360 | -67.183% | 1,097 | 1,328 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 0 | |||
| 360 | -67.183% | 1,097 | 1,328 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 70 | 0.000% | 70 | 70 | ||||
| Reserves | 241,205 | -38.280% | 390,805 | 652,535 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 241,275 | -38.273% | 390,875 | 652,605 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 241,275 | -38.273% | 390,875 | 652,605 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 0 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 19/03/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -182,242,000 |
| %Change | -26.978% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |